DEFINITIVE PROXY STATEMENT

Company

Ensysce Biosciences, Inc.

Filed

March 3, 2020

Period of Report

March 26, 2020

Accession Number

0001213900-20-005315

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →